ValtrexTM Therapy for Epstein-Barr Virus Reactivation and Upper Respiratory Symptoms in Elite Runners
- 1 July 2004
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine & Science in Sports & Exercise
- Vol. 36 (7), 1104-1110
- https://doi.org/10.1249/01.mss.0000131957.40985.2b
Abstract
COX, A. J., M. GLEESON, D. B. PYNE, P. U. SAUNDERS, R. L. CLANCY, and P. A. FRICKER. ValtrexTM Therapy for Epstein-Barr Virus Reactivation and Upper Respiratory Symptoms in Elite Runners. Med. Sci. Sports Exerc., Vol. 36, No. 7, pp. 1104–1110, 2004.Purpose:The aim of the study was to examineKeywords
This publication has 16 references indexed in Scilit:
- One year in Antarctica: Mucosal immunity at three Australian stationsImmunology & Cell Biology, 2000
- FUSAFUNGINE REDUCES SYMPTOMS OF UPPER RESPIRATORY TRACT INFECTIONS (URTI) IN RUNNERS AFTER A 56KM RACE 1685Medicine & Science in Sports & Exercise, 1997
- Immunity in AthletesInternational Journal of Sports Medicine, 1997
- The effect on immunity of long-term intensive training in elite swimmersClinical and Experimental Immunology, 1995
- Effect of High- Versus Moderate-Intensity Exercise on Lymphocyte Subpopulations and Proliferative ResponseInternational Journal of Sports Medicine, 1994
- Exercise, upper respiratory tract infection, and the immune systemMedicine & Science in Sports & Exercise, 1994
- Acyclovir treatment in infectious mononucleosis: A clinical and virological studyInfection, 1987
- A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individualsInternational Journal of Cancer, 1985
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984
- Stress and the transformation of lymphocytes by Epstein-Barr virusJournal of Behavioral Medicine, 1984